EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 19 aprīlis 2024. Database contains 4917 unique substances/entries.
Filter the list
|
-
|
15271-41-7
|
Acute Tox. 2; Acute Tox. 3 |
Details | |||
|
210-467-4
|
616-20-6
|
Flam. Liq. 2; Acute Tox. 4 |
Details | |||
|
203-582-6
|
108-43-0
|
Acute Tox. 4 |
Details | |||
|
203-457-6
|
107-05-1
|
Flam. Liq. 2; Carc. 2; Muta. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
Details | |||
|
CHLOROFORMIATE DE CHLORO 3 PROPYLE
|
425-770-9
|
628-11-5
|
Acute Tox. 3; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
203-580-5
|
108-41-8
|
Acute Tox. 4 |
Details | |||
|
ISOPHORONENITRILE, IPN
|
411-490-4
|
7027-11-4
|
Acute Tox. 4; STOT RE 2; Skin Sens. 1 |
Details | ||
|
SANDUVOR 3056
|
411-920-0
|
106917-30-0
|
Acute Tox. 3; Acute Tox. 4; STOT RE 2; Skin Corr. 1A |
Details | ||
|
UK-48,340
|
425-820-1
|
88150-42-9
|
Acute Tox. 3; STOT RE 2; Eye Dam. 1 |
Details | ||
|
ZOLDINE MS-PLUS
|
421-150-7
|
143860-04-2
|
Repr. 1B; Skin Corr. 1B |
R Toxic for reproduction (article 57c) |
Details | |
|
210-187-2
|
609-26-7
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
Details | |||
|
213-923-0
|
1067-08-9
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
Details | |||
|
210-621-0
|
619-99-8
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
Details | |||
|
210-529-0
|
617-78-7
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
Details | |||
|
428-700-5
|
1873-90-1
|
Acute Tox. 4 |
Details | |||
|
LUPEROX 610-E-35; LUPEROX 610-E-50; LUPEROX 610-EN-50; LUPEROX 610-M-50; LUPERSOL 610; LUPERSOL 610-M-50
|
413-910-1
|
1467668-33-2
|
Org. Perox. C; Flam. Liq. 3; Skin Irrit. 2 |
Details | ||
|
220-426-2
|
2761-09-3
|
Eye Irrit. 2; Skin Sens. 1 |
Details | |||
|
259-627-5
|
55406-53-6
|
Acute Tox. 3; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1 |
Details | |||
|
209-130-4
|
556-56-9
|
Flam. Liq. 2; Skin Corr. 1B |
Details | |||
|
223-861-6
|
4098-71-9
|
Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
433-900-0
|
55066-49-4
|
Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1 |
Details | |||
|
SUBSTANCE S44176
|
414-570-7
|
18759-96-1
|
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
Details | ||
|
209-264-3
|
563-80-4
|
Flam. Liq. 2 |
Details | |||
|
209-660-6
|
589-81-1
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
Details | |||
|
209-643-3
|
589-34-4
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
Details | |||
|
202-481-4
|
96-14-0
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
Details | |||
|
-
|
2532-43-6
|
Acute Tox. 3 |
Details | |||
|
215-925-7
|
1453-58-3
|
Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Corr. 1; Eye Dam. 1 |
Details | |||
|
432-530-7
|
24294-01-7
|
Acute Tox. 4 |
Details | |||
|
CC14837; SKF 106224
|
414-990-0
|
302-97-6
|
Repr. 2 |
Details | ||
|
209-526-7
|
584-02-1
|
Flam. Liq. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2 |
Details | |||
|
200-340-1
|
57-57-8
|
Carc. 1B; Acute Tox. 2; Eye Irrit. 2; Skin Irrit. 2 |
Details | |||
|
Z-29
|
418-990-1
|
778577-53-0
|
STOT RE 2; Eye Irrit. 2; Skin Irrit. 2 |
Details | ||
|
201-052-9
|
77-73-6
|
Flam. Liq. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
Details | |||
|
LICHTSCHUTZMITTEL 2577
|
407-600-5
|
120187-29-3
|
Muta. 2 |
Details | ||
|
DMA
|
407-500-1
|
21983-80-2
|
Skin Sens. 1 |
Details | ||
|
428-970-4
|
13595-25-0
|
Repr. 2; Skin Sens. 1 |
Details | |||
|
201-025-1
|
77-40-7
|
END Endocrine disrupting properties (Article 57(f) - human health) ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
209-321-2
|
569-61-9
|
Carc. 1B |
Details | |||
|
DIGLYCERINDIFORMAL (DGDF)
|
423-230-7
|
56552-15-9
|
Eye Dam. 1 |
Details | ||
|
216-036-7
|
1478-61-1
|
Repr. 1B |
Details | |||
|
204-358-0
|
119-93-7
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
209-218-2
|
561-41-1
|
C Carcinogenic (article 57a) |
Details | |||
|
202-027-5
|
90-94-8
|
Carc. 1B; Muta. 2; Eye Dam. 1 |
C Carcinogenic (article 57a) |
Details | ||
|
B-TUM
|
418-770-5
|
151882-81-4
|
Carc. 2 |
Details | ||
|
207-762-5
|
492-80-8
|
Carc. 2; Acute Tox. 4; Eye Irrit. 2 |
Details | |||
|
ZP-DK 2115
|
407-590-2
|
43151-99-1
|
Acute Tox. 3; STOT RE 2; Skin Sens. 1 |
Details | ||
|
202-974-4
|
101-77-9
|
Carc. 1B; Muta. 2; STOT SE 1; STOT RE 2; Skin Sens. 1 |
C Carcinogenic (article 57a) |
Details | ||
|
AROCY L-10
|
405-740-1
|
47073-92-7
|
Acute Tox. 4; STOT RE 2; Eye Dam. 1 |
Details | ||
|
420-530-1
|
177027-34-8
|
Resp. Sens. 1; Skin Sens. 1 |
Details | |||